stockrowPTC Therapeutics, Inc.
PTCT Healthcare Biotechnology
PTC Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.7 billion, up 114.5% from fiscal 2024.
- Revenue
- +69.6%
- EPS
- −409.7%
- Free cash flow
- +90.3%
- Total debt
- +19.3%
Quarter to September 2026, against a year earlier
Follow PTCT
Alert me
PTC Therapeutics, Inc. (PTCT) Gross margin
PTC Therapeutics, Inc.'s gross margin over the twelve months to 30 September 2026 was 93.2%, down 4.1 percentage points from fiscal 2025 (97.3%). Over the past ten years it has ranged from 92.9% (fiscal 2024) to 100.0% (fiscal 2016); the current reading is higher than 73% of that period. That is above the Biotechnology industry median of 65.2% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 97.3% | 4.39 |
| FY2024 | 92.9% | (0.13) |
| FY2023 | 93.0% | (0.59) |
| FY2022 | 93.6% | (0.39) |
| FY2021 | 94.0% | (1.03) |
| FY2020 | 95.0% | (1.02) |
| FY2019 | 96.1% | 0.84 |
| FY2018 | 95.2% | (2.44) |
| FY2017 | 97.7% | (2.35) |
| FY2016 | 100.0% | 0.00 |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 93.4% | (1.08) |
| Jun 2026 | 94.5% | 4.75 |
| Mar 2026 | 89.7% | (6.06) |
| Dec 2025 | 95.8% | 3.26 |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| PTCT PTC Therapeutics, Inc. | 93.2% |
| MIRM Mirum Pharmaceuticals, Inc. compare | 81.7% |
| COGT Cogent Biosciences, Inc. compare | 0.00% |
| KOD Kodiak Sciences Inc. compare | 0.00% |
| IMVT Immunovant, Inc. compare | 0.00% |
| SRRK Scholar Rock Holding Corporation compare | 0.00% |
| CGON CG Oncology, Inc. compare | −85.2% |
| BLTE Belite Bio, Inc. Sponsored ADR compare | — |
| MANE Veradermics Incorporated compare | — |
| Biotechnology industry median | 65.2% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on PTCT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement